Verification evidence is still being completed.
PDF / print export
Aidian
Espoo, Finland
- Verified lead
- Antti Koivula
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO (interim) and CFO
- 2026 technical specialization
- Point-of-Care Diagnostics, Molecular Diagnostics, Microbiology, and Hygiene Monitoring
- Review cycle
- May 2026
- Full address
- Koivu-Mankkaan tie 6 B, FI-02200 Espoo, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Aidian management page confirming the current interim leadership in Espoo.
- Editorial note
- Aidian remains under Antti Koivula's interim leadership in March 2026, while the company has already disclosed Torben Nielsen's appointment as incoming CEO for a later June 2026 handover.
Point-of-Care Diagnostics, Molecular Diagnostics, Microbiology, and Hygiene Monitoring
ISO 13485, IVDR-certified quality system, FDA requirements
Aidian remains under Antti Koivula's interim leadership in March 2026, while the company has already disclosed Torben Nielsen's appointment as incoming CEO for a later June 2026 handover.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Espoo, Finland
Aidian
Point-of-Care Diagnostics, Molecular Diagnostics, Microbiology, and Hygiene Monitoring · Global IVD manufacturing and distribution support
Aidian remains under Antti Koivula's interim leadership in March 2026, while the company has already disclosed Torben Nielsen's appointment as incoming CEO for a later June 2026 handover.
- Lead
- Antti Koivula (verified ↗)
- Address
- Koivu-Mankkaan tie 6 B, FI-02200 Espoo, Finland (source ↗)
- Compliance
- ISO 13485 · FDA requirements
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Global IVD manufacturing and distribution support
- Capabilities
- Point-of-Care Testing · Molecular Diagnostics · Microbiology and Hygiene Monitoring
- Founded
- 1974
- Headcount
- 201-500
- Contact email
- [email protected] (email ↗)
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Antti Koivula
CEO (interim) and CFO
Full addressKoivu-Mankkaan tie 6 B, FI-02200 Espoo, Finland
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Global IVD manufacturing and distribution support
Espoo, Finland. Point-of-Care Diagnostics, Molecular Diagnostics, Microbiology, and Hygiene Monitoring. Review completed on 21 Mar 2026.
EU IVDR, FDA requirements, and IVD quality oversight
ISO 13485, IVDR-certified quality system, FDA requirements
Point-of-Care Diagnostics, Molecular Diagnostics, Microbiology, and Hygiene Monitoring
Aidian remains under Antti Koivula's interim leadership in March 2026, while the company has already disclosed Torben Nielsen's appointment as incoming CEO for a later June 2026 handover.
Editorial note
Aidian remains under Antti Koivula's interim leadership in March 2026, while the company has already disclosed Torben Nielsen's appointment as incoming CEO for a later June 2026 handover.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Point-of-Care Testing
Molecular Diagnostics
Microbiology and Hygiene Monitoring
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
QuikRead go platform manufacturing
Diagnostics quality laboratories
Product development and support systems
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- VERIFIED ACTIVE 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Aidian located?
- Aidian operates from Koivu-Mankkaan tie 6 B, FI-02200 Espoo, Finland, Espoo, Finland.
- Who runs Aidian?
- Aidian is led by Antti Koivula, CEO (interim) and CFO. Verified 21 Mar 2026.
- What certifications does Aidian hold?
- Aidian is documented under ISO 13485, FDA requirements.
- What does Aidian do?
- Aidian remains under Antti Koivula's interim leadership in March 2026, while the company has already disclosed Torben Nielsen's appointment as incoming CEO for a later June 2026 handover. Core capabilities: Point-of-Care Testing, Molecular Diagnostics, Microbiology and Hygiene Monitoring.
Editorial context
Related technical briefs
Briefs that name Espoo as a covered market or city.